• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Bonuses, 401k, Quotas ???

Quote
















anonymous said:
That equates to a short life expectancy at Slopko. The president of the Lolipop Guild won’t put up with independent thought.
Click to expand...
Similar comment here. Every management employee who doesn’t drink the kool-aid has been pushed out already. The only ones who will survive the wrath at Slopko are the brown-nosed losers. If DH isn’t one of them, his days here are numbered. He definitely has a target on his back.
 




anonymous said:
Similar comment here. Every management employee who doesn’t drink the kool-aid has been pushed out already. The only ones who will survive the wrath at Slopko are the brown-nosed losers. If DH isn’t one of them, his days here are numbered. He definitely has a target on his back.
Click to expand...
There are many innovative, first in class drugs coming to market with companies with proven management. OPKO is not one of them. This is a plaything for an old man looking at the grave.
 












anonymous said:
I wonder if we will ever get any of those things? It is really ironic that RR wants business plans but to hold back our money, really? Are we being punked?
Click to expand...
Yes, you are. Nothing has changed SOP not as much from RR but from the ancient old man that has the first nickel he made in 1920. But hey, take some pride in that your forgone cash has gone to fund art museums, a nice aquarium, and don’t forget Steve Wynn’s used 757.
 




Top Bottom
Back
Quote